A part of Watch Media

MedWatchWednesday4 October 2023

  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
MedWatchWednesday4 October 2023
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
Hearing health

Per Wold-Olsen on 15 years as chairman of GN: "A very positive, rewarding journey"

When Per Wold-Olsen became chair of GN Group in 2008, it was not a given that the company would survive, according to the man himself. In March, he stepped down after 15 eventful years as chairman.
Norwegian national Per Wold-Olsen joined GN Store Nord as chair of the Board in 2008. | Photo: Mik Eskestad
Norwegian national Per Wold-Olsen joined GN Store Nord as chair of the Board in 2008. | Photo: Mik Eskestad
by CHRISTOPHER DUE KARLSSON

With less than 24 hours until the long-standing chairman, Norwegian Per Wold-Olsen, is to take the podium for the last time at GN Store Nord’s annual general meeting back in March, the audio group suddenly has to issue a stock exchange announcement. 

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Related articles:

  • Per Wold-Olsen officially stepped down as GN's chair at the company's AGM | Photo: Mik Eskestad

    Former GN chair says there have been no acquisition signs from Demant owner

    For subscribers

  • Per Wold-Olsen, outgoing chairman of GN's board | Photo: Mik Eskestad

    GN's veteran chairman to retire

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Foto: Tom Little
Pharma & biotech

Investment bank: Novo Nordisk's patent victory is a small victory as price negotiations loom

The market’s attention is more focused on public health insurance Medicare’s new price negotiations under the so-called Inflation Reduction Act.
  • Bank downplays importance of patent dispute and FDA notice to Novo Nordisk
  • Jefferies on Novo Nordisk: Little risk of semaglutide patent dispute - but could raise concerns

For subscribers



Foto: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

For subscribers



Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

For subscribers


Foto: Andrew Kelly/Reuters/Ritzau Scanpix
Pharma & biotech

Low share price may knock Galecto off the stock exchange

For subscribers


Foto: Mike Segar/Reuters/Ritzau Scanpix
Pharma & biotech

Snack maker keeps an eye on Novo Nordisk's obesity drug


Foto: Yuriko Nakao/Reuters/Ritzau Scanpix
Medtech

Olympus appoints new chief medical officer

For subscribers


  • Foto: Alexander Heinl/AP/Ritzau Scanpix

    Novo Nordisk's semaglutide to be studied for positive effect on alcoholics

    Previous studies have shown that alcohol cravings disappeared when people were treated with GLP-1 agonist exanatide.

    For subscribers


  • Vaccine breakthrough behind mRNA shots wins Nobel Prize

    The two scientists will share the 11 million-krona ( USD 1 million) award, the Nobel Assembly at the Karolinska Institutet in Stockholm said in a statement Monday.

    For subscribers


  • Foto: Ws Audiology / Pr

    WS Audiology hires new chief technology officer from car manufacturer

    He succeeds chief research & development officer Stefan Menzl, who is stepping down after six years.

    For subscribers


  • Foto: Tom Little

    Novo Nordisk files lawsuit against US authorities ahead of price negotiation

    The litigation is the latest in a long line of industry lawsuits related to price negotiations.

    For subscribers


  • Foto: Mike Segar

    FDA rejects atopic dermatitis drug lebrikizumab

    Eli Lilly had expected a launch this year.

    For subscribers


  • The FDA has updated the package label of Novo Nordisk's diabetes drug, Ozempic, with a warning about intestinal blockage disorder as a possible side effect. | Foto: Tom Little/Reuters/Ritzau Scanpix

    FDA updates Novo Nordisk's Ozempic drug label with side effect alert

    The diabetes drug might cause a potentially fatal intestinal blockage, the authorities warn.

    For subscribers


Further reading

Foto: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

The marketing authorization applies to children and adolescents aged 9 years and older, as well as adults with ”relatively” preserved kidney functions.

For subscribers



Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

The contract manufacturer has hired a chief people officer with immediate effect.

For subscribers



Foto: Gn/pr
Hearing health

GN chairman reassures on company's future on top of management change

The board of GN is convinced that keeping the company together creates more value for shareholders.

For subscribers


Foto: Jukka Pekka Pertola / Privat
Hearing health

GN: Merger of Hearing and Audio divisions will boost innovation

The products in GN’s two divisions are becoming more and more similar, says Chairman of the Board Jukka Pertola.

For subscribers



Robert Langer has received several honorary awards in his career. Here, he is pictured in 2013, when then US President Barack Obama presented him with the National Medal of Technology and Innovation. | Foto: Charles Dharapak/AP/Ritzau Scanpix
Pharma & biotech

Robert Langer to open doors for young biotech company: "But ultimately people need to be convinced by the idea and the data"

With Robert Langer on board, Hervolution will have a huge network of professionals to benefit from, and the renowned scientist’s reputation will increase investor interest, according to the analysis.

For subscribers



Foto: Gn / Pr
Hearing health

New GN platform completes ten years of connectivity work

Resound Nexia will be the first hearing aid to utilize the new Bluetooth low energy standard to connect to any Bluetooth-enabled device. It has taken ten years to accomplish.

For subscribers


Jobs

  • Qualified Person to AJ Vaccines

  • Senior Analytical Scientists

  • Senior Legal Councel

  • VP of Software Development, Perfusion Tech

  • Project Director, HR & ESG

  • QA/RA Manager

  • Director, Head of Antibody Technology

  • Clinical Trial Manager

  • Audit & Supplier Manager

  • Scientist - Bioanalysis, Biologics

  • Supply Value Stream (SVS) Project Manager

  • Global Medical Manager

  • Senior QA Specialists (GMP or GCP)

  • Senior CMC Specialist, Upstream Processing, Genmab

  • Clinical Supply Manager

See all jobs

Latest news

  • Investment bank: Novo Nordisk's patent victory is a small victory as price negotiations loom –
  • Novo Nordisk's semaglutide to be studied for positive effect on alcoholics –
  • Olympus appoints new chief medical officer –
  • Low share price may knock Galecto off the stock exchange –
  • Fujifilm expands management with former Leo executive –
  • Snack maker keeps an eye on Novo Nordisk's obesity drug –
  • FDA approves Novo Nordisk drug to treat rare condition –
  • FDA updates Novo Nordisk's Ozempic drug label with side effect alert –
  • FDA rejects atopic dermatitis drug lebrikizumab –
  • FDA to support new orphan drugs through pilot program –
See all

Jobs

  • Qualified Person to AJ Vaccines

  • Senior Analytical Scientists

  • Senior Legal Councel

  • VP of Software Development, Perfusion Tech

  • Project Director, HR & ESG

  • QA/RA Manager

  • Director, Head of Antibody Technology

  • Clinical Trial Manager

  • Audit & Supplier Manager

  • Scientist - Bioanalysis, Biologics

  • Supply Value Stream (SVS) Project Manager

  • Global Medical Manager

  • Senior QA Specialists (GMP or GCP)

  • Senior CMC Specialist, Upstream Processing, Genmab

  • Clinical Supply Manager

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

  • About MedWatch

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Banner Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved